Epigenetic inactivation of the E-cadherin gene in eyelid sebaceous gland carcinoma

British Journal of Dermatology

Volumn 167, Issue 3, 2012, Pages 583-590

  Jayaraj, P ^a   Sen, S ^a   Sharma, A ^a   Chosdol, K ^a   Kashyap, S ^a   Rai, A ^b   Pushker, N ^c   Bajaj, M S ^c   Ghose, S ^c  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

^b National Centre for Disease Control   (India)

^c ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; UVOMORULIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE FREE SURVIVAL; DNA SEQUENCE; EPIGENETICS; EYELID CARCINOMA; FEMALE; GENE INACTIVATION; GENE MUTATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MALE; METHYLATION; MUTATIONAL ANALYSIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SEBACEOUS CARCINOMA; TUMOR RECURRENCE; TUMOR VOLUME;

ADULT; AGED; BETA CATENIN; CADHERINS; DNA METHYLATION; DNA MUTATIONAL ANALYSIS; EPIGENESIS, GENETIC; EYELID NEOPLASMS; FEMALE; GENE SILENCING; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; MUTATION; POLYMERASE CHAIN REACTION; PROGNOSIS; PROMOTER REGIONS, GENETIC; SEBACEOUS GLAND NEOPLASMS;

EID: 84865583740     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2012.10968.x     Document Type: Article

References (40)

1. Alsaad KO, Obaidat NA, Ghazarian D,. Skin adnexal neoplasms-part 1: an approach to tumours of the pilosebaceous unit. J Clin Pathol 2007; 60: 129-44.
2. Abdi U, Tyagi N, Maheshwari V, et al. Tumours of eyelid: a clinicopathologic study. J Indian Med Assoc 1996; 94: 405-9, 416, 418.
3. Ni C, Searl SS, Kuo PK, et al. Sebaceous cell carcinomas of the ocular adnexa. Int Ophthalmol Clin 1982; 22: 23-61.
4. Jayaraj P, Sen S, Kashyap S, et al. Does β-catenin have a role in pathogenesis of sebaceous cell carcinoma of the eyelid? Br J Ophthalmol 2011; 95: 284-7.
5. Muqit MMK, Roberts F, Lee WR, et al. Improved survival rates in sebaceous carcinoma of the eyelid. Eye (Lond) 2004; 18: 49-53. (Pubitemid 38180895)
6. Chao AN, Shields CL, Krema H, et al. Outcome of patients with periocular sebaceous gland carcinoma with and without conjunctival intraepithelial invasion. Ophthalmology 2001; 108: 1877-83. (Pubitemid 32905949)
7. Ho VH, Ross MI, Prieto VG, et al. Sentinel lymph node biopsy for sebaceous cell carcinoma and melanoma of the ocular adnexa. Arch Otolaryngol Head Neck Surg 2007; 133: 820-6. (Pubitemid 47295766)
8. Takeichi M,. Cadherin cell adhesion receptors as a morphogenetic regulator. Science 1991; 251: 1451-5. (Pubitemid 121000430)
9. Hennig G, Löwrick O, Birchmeier W, Behrens J,. Mechanisms identified in the transcriptional control of epithelial gene expression. J Biol Chem 1996; 271: 595-602. (Pubitemid 26026630)
10. Esteller M,. CpG island hypermethylation and tumor suppressor genes: a booming present, a brighter future. Oncogene 2002; 21: 5427-40. (Pubitemid 34983479)
11. Chiles MC, Ai L, Zuo C, et al. E-cadherin promoter hypermethylation in preneoplastic and neoplastic skin lesions. Mod Pathol 2003; 16: 1014-18. (Pubitemid 37280817)
12. Sathyanarayana UG, Moore AY, Li L, et al. Sun exposure related methylation in malignant and non-malignant skin lesions. Cancer Lett 2007; 245: 112-20. (Pubitemid 44959343)
13. Young C-H, Chiu Y-T, Shih T-S, et al. E-cadherin promoter hypermethylation may contribute to protein inactivation in pterygia. Mol Vis 2010; 16: 1047-53.
14. Pizarro A, Benito N, Navarro P, et al. E-cadherin expression in basal cell carcinoma. Br J Cancer 1994; 69: 157-62. (Pubitemid 24021840)
15. Polakis P,. Wnt signaling and cancer. Genes Dev 2000; 14: 1837-51. (Pubitemid 30639518)
16. Graziano F, Arduini F, Ruzzo A, et al. Combined analysis of E-cadherin gene (CDH1) promoter hypermethylation and E-cadherin protein expression in patients with gastric cancer: implications for treatment with demethylating drugs. Ann Oncol 2004; 15: 489-92. (Pubitemid 38444555)
17. Chan AO-O, Lam S-K, Wong BC-Y, et al. Promoter methylation of E-cadherin gene in gastric mucosa associated with Helicobacter pylori infection and in gastric cancer. Gut 2003; 52: 502-6. (Pubitemid 36363400)
18. Graff JR, Greenberg VE, Herman JG, et al. Distinct patterns of E-cadherin CpG island methylation in papillary, follicular, Hurthle's cell, and poorly differentiated human thyroid carcinoma. Cancer Res 1998; 58: 2063-6. (Pubitemid 28232884)
19. Papadavid E, Pignatelli M, Zakynthinos S, et al. Abnormal immunoreactivity of the E-cadherin/catenin (alpha-, beta-, and gamma-) complex in premalignant and malignant non-melanocytic skin tumours. J Pathol 2002; 196: 154-62. (Pubitemid 34110896)
20. Ainbinder DJ, Esmaeli B, Groo SC, et al. Introduction of the 7th edition eyelid carcinoma classification system from the American Joint Committee on Cancer-International Union Against Cancer staging manual. Arch Pathol Lab Med 2009; 133: 1256-61.
21. Hsu SM, Raine L, Fanger H,. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem 1981; 29: 577-80. (Pubitemid 11147380)
22. Bornman DM, Mathew S, Alsruhe J, et al. Methylation of the E-cadherin gene in bladder neoplasia and in normal urothelial epithelium from elderly individuals. Am J Pathol 2001; 159: 831-5. (Pubitemid 32847174)
23. Herman JG, Graff JR, Myöhänen S, et al. Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci USA 1996; 93: 9821-6. (Pubitemid 26296693)
24. Kudo Y, Kitajima S, Ogawa I, et al. Invasion and metastasis of oral cancer cells require methylation of E-cadherin and/or degradation of membranous beta-catenin. Clin Cancer Res 2004; 10: 5455-63. (Pubitemid 39100483)
25. Doglioni C, Piccinin S, Demontis S, et al. Alterations of beta-catenin pathway in non-melanoma skin tumors: loss of alpha-ABC nuclear reactivity correlates with the presence of beta-catenin gene mutation. Am J Pathol 2003; 163: 2277-87. (Pubitemid 37466472)
26. Caldeira JRF, Prando EC, Quevedo FC, et al. CDH1 promoter hypermethylation and E-cadherin protein expression in infiltrating breast cancer. BMC Cancer 2006; 6: 48.
27. Murao K, Kubo Y, Ohtani N, et al. Epigenetic abnormalities in cutaneous squamous cell carcinomas: frequent inactivation of the RB1/p16 and p53 pathways. Br J Dermatol 2006; 155: 999-1005. (Pubitemid 44564511)
28. Chang HW, Chow V, Lam KY, et al. Loss of E-cadherin expression resulting from promoter hypermethylation in oral tongue carcinoma and its prognostic significance. Cancer 2002; 94: 386-92. (Pubitemid 34081367)
29. Kanazawa T, Watanabe T, Kazama S, et al. Poorly differentiated adenocarcinoma and mucinous carcinoma of the colon and rectum show higher rates of loss of heterozygosity and loss of E-cadherin expression due to methylation of promoter region. Int J Cancer 2002; 102: 225-9. (Pubitemid 35222288)
30. Saito T, Nishimura M, Yamasaki H, Kudo R,. Hypermethylation in promoter region of E-cadherin gene is associated with tumor dedifferention and myometrial invasion in endometrial carcinoma. Cancer 2003; 97: 1002-9. (Pubitemid 36173151)
31. Wheeler JM, Kim HC, Efstathiou JA, et al. Hypermethylation of the promoter region of the E-cadherin gene (CDH1) in sporadic and ulcerative colitis associated colorectal cancer. Gut 2001; 48: 367-71. (Pubitemid 32269565)
32. Batlle E, Sancho E, Francí C, et al. The transcription factor snail is a repressor of E-cadherin gene expression in epithelial tumour cells. Nat Cell Biol 2000; 2: 84-9.
33. Hirohashi S,. Inactivation of the E-cadherin-mediated cell adhesion system in human cancers. Am J Pathol 1998; 153: 333-9. (Pubitemid 28373643)
34. Sommers CL, Gelmann EP, Kemler R, et al. Alterations in beta-catenin phosphorylation and plakoglobin expression in human breast cancer cells. Cancer Res 1994; 54: 3544-52.
35. Cheng CW, Wu PE, Yu JC, et al. Mechanisms of inactivation of E-cadherin in breast carcinoma: modification of the two-hit hypothesis of tumor suppressor gene. Oncogene 2001; 20: 3814-23.
36. Karam R, Carvalho J, Bruno I, et al. The NMD mRNA surveillance pathway downregulates aberrant E-cadherin transcripts in gastric cancer cells and in CDH1 mutation carriers. Oncogene 2008; 27: 4255-60. (Pubitemid 351969914)
37. Kase S, Sugio K, Yamazaki K, et al. Expression of E-cadherin and beta-catenin in human non-small cell lung cancer and the clinical significance. Clin Cancer Res 2000; 6: 4789-96. (Pubitemid 32110421)
38. Jeanes A, Gottardi CJ, Yap AS,. Cadherins and cancer: how does cadherin dysfunction promote tumor progression? Oncogene 2008; 27: 6920-9.
39. Wong CM, Fan ST, Ng IO,. beta-Catenin mutation and overexpression in hepatocellular carcinoma: clinicopathologic and prognostic significance. Cancer 2001; 92: 136-45. (Pubitemid 32623050)
40. Kazakov DV, Sima R, Vanecek T, et al. Mutations in exon 3 of the CTNNB1 gene (β-catenin gene) in cutaneous adnexal tumors. Am J Dermatopathol 2009; 31: 248-55.